These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23129208)

  • 1. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
    Bidard FC; Fehm T; Ignatiadis M; Smerage JB; Alix-Panabières C; Janni W; Messina C; Paoletti C; Müller V; Hayes DF; Piccart M; Pierga JY
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):179-88. PubMed ID: 23129208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial.
    Helissey C; Berger F; Cottu P; Diéras V; Mignot L; Servois V; Bouleuc C; Asselain B; Pelissier S; Vaucher I; Pierga JY; Bidard FC
    Cancer Lett; 2015 May; 360(2):213-8. PubMed ID: 25700777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study.
    Paoletti C; Miao J; Dolce EM; Darga EP; Repollet MI; Doyle GV; Gralow JR; Hortobagyi GN; Smerage JB; Barlow WE; Hayes DF
    Clin Cancer Res; 2019 Oct; 25(20):6089-6097. PubMed ID: 31358544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
    Schramm A; Friedl TW; Schochter F; Scholz C; de Gregorio N; Huober J; Rack B; Trapp E; Alunni-Fabbroni M; Müller V; Schneeweiss A; Pantel K; Meier-Stiegen F; Hartkopf A; Taran FA; Wallwiener D; Janni W; Fehm T
    Arch Gynecol Obstet; 2016 Feb; 293(2):271-81. PubMed ID: 26354331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.
    Smerage JB; Budd GT; Doyle GV; Brown M; Paoletti C; Muniz M; Miller MC; Repollet MI; Chianese DA; Connelly MC; Terstappen LW; Hayes DF
    Mol Oncol; 2013 Jun; 7(3):680-92. PubMed ID: 23538216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.
    Müller V; Riethdorf S; Rack B; Janni W; Fasching PA; Solomayer E; Aktas B; Kasimir-Bauer S; Pantel K; Fehm T;
    Breast Cancer Res; 2012 Aug; 14(4):R118. PubMed ID: 22894854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-targeted therapy influences CTC status in metastatic breast cancer.
    Deutsch TM; Riethdorf S; Fremd C; Feisst M; Nees J; Fischer C; Hartkopf AD; Pantel K; Trumpp A; Schütz F; Schneeweiss A; Wallwiener M
    Breast Cancer Res Treat; 2020 Jul; 182(1):127-136. PubMed ID: 32436146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer.
    Gasch C; Oldopp T; Mauermann O; Gorges TM; Andreas A; Coith C; Müller V; Fehm T; Janni W; Pantel K; Riethdorf S
    Mol Oncol; 2016 Oct; 10(8):1330-43. PubMed ID: 27491860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.
    Wallwiener M; Hartkopf AD; Baccelli I; Riethdorf S; Schott S; Pantel K; Marmé F; Sohn C; Trumpp A; Rack B; Aktas B; Solomayer EF; Müller V; Janni W; Schneeweiss A; Fehm TN
    Breast Cancer Res Treat; 2013 Jan; 137(2):503-10. PubMed ID: 23271327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
    Cabel L; Berger F; Cottu P; Loirat D; Rampanou A; Brain E; Cyrille S; Bourgeois H; Kiavue N; Deluche E; Ladoire S; Campone M; Pierga JY; Bidard FC
    Br J Cancer; 2021 Mar; 124(7):1207-1213. PubMed ID: 33473163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients.
    Zhang S; Li L; Wang T; Bian L; Hu H; Xu C; Liu B; Liu Y; Cristofanilli M; Jiang Z
    BMC Cancer; 2016 Jul; 16():526. PubMed ID: 27456503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients.
    Liu XR; Shao B; Peng JX; Li HP; Yang YL; Kong WY; Song GH; Jiang HF; Liang X; Yan Y
    Breast; 2017 Apr; 32():119-125. PubMed ID: 28157583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.
    Liu MC; Shields PG; Warren RD; Cohen P; Wilkinson M; Ottaviano YL; Rao SB; Eng-Wong J; Seillier-Moiseiwitsch F; Noone AM; Isaacs C
    J Clin Oncol; 2009 Nov; 27(31):5153-9. PubMed ID: 19752342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
    Bidard FC; Michiels S; Riethdorf S; Mueller V; Esserman LJ; Lucci A; Naume B; Horiguchi J; Gisbert-Criado R; Sleijfer S; Toi M; Garcia-Saenz JA; Hartkopf A; Generali D; Rothé F; Smerage J; Muinelo-Romay L; Stebbing J; Viens P; Magbanua MJM; Hall CS; Engebraaten O; Takata D; Vidal-Martínez J; Onstenk W; Fujisawa N; Diaz-Rubio E; Taran FA; Cappelletti MR; Ignatiadis M; Proudhon C; Wolf DM; Bauldry JB; Borgen E; Nagaoka R; Carañana V; Kraan J; Maestro M; Brucker SY; Weber K; Reyal F; Amara D; Karhade MG; Mathiesen RR; Tokiniwa H; Llombart-Cussac A; Meddis A; Blanche P; d'Hollander K; Cottu P; Park JW; Loibl S; Latouche A; Pierga JY; Pantel K
    J Natl Cancer Inst; 2018 Jun; 110(6):560-567. PubMed ID: 29659933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
    Jacot W; Cottu P; Berger F; Dubot C; Venat-Bouvet L; Lortholary A; Bourgeois H; Bollet M; Servent V; Luporsi E; Espié M; Guiu S; D'Hondt V; Dieras V; Sablin MP; Brain E; Neffati S; Pierga JY; Bidard FC
    Breast Cancer Res; 2019 Nov; 21(1):121. PubMed ID: 31727113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells in breast cancer patients: prognostic predictive role.
    Turker I; Uyeturk U; Sonmez OU; Oksuzoglu B; Helvaci K; Arslan UY; Budakoglu B; Alkis N; Aksoy S; Zengin N
    Asian Pac J Cancer Prev; 2013; 14(3):1601-7. PubMed ID: 23679243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.
    Bidard FC; Mathiot C; Delaloge S; Brain E; Giachetti S; de Cremoux P; Marty M; Pierga JY
    Ann Oncol; 2010 Apr; 21(4):729-733. PubMed ID: 19850639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.